Table 3. OR (95% CI) for the prevalence of diabetic conditions.
Cystatin Ca | ORb (95% CI) | P value | ORc (95% CI) | P value | ORd (95% CI) | P value |
---|---|---|---|---|---|---|
Total | ||||||
First | 1 (reference) | 1 (reference) | 1 (reference) | |||
Second | 1.26 (0.86–1.84) | 0.232 | 1.06 (0.71–1.59) | 0.756 | 1.01 (0.65–1.49) | 0.940 |
Third | 1.44 (0.99–2.09) | 0.055 | 0.99 (0.66–1.48) | 0.963 | 0.89 (0.58–1.35) | 0.588 |
Fourth | 1.29 (0.86–1.94) | 0.210 | 0.75 (0.48–1.17) | 0.215 | 0.61 (0.39–0.97) | 0.037 |
Fifth | 2.35 (1.54–3.58) | <0.001 | 1.21 (0.76–1.92) | 0.420 | 1.01 (0.62–1.63) | 0.964 |
Men | ||||||
First | 1 (reference) | 1 (reference) | 1 (reference) | |||
Second | 0.75 (0.42–1.33) | 0.329 | 0.92 (0.50–1.69) | 0.802 | 0.84 (0.46–1.54) | 0.584 |
Third | 0.75 (0.43–1.31) | 0.321 | 0.56 (0.31–1.01) | 0.055 | 0.67 (0.37–1.21) | 0.187 |
Fourth | 0.63 (0.35–1.12) | 0.119 | 0.72 (0.41–1.28) | 0.268 | 0.48 (0.26–0.88) | 0.019 |
Fifth | 1.17 (0.65–2.10) | 0.589 | 0.88 (0.49–1.58) | 0.675 | 0.81 (0.43–1.52) | 0.522 |
Women | ||||||
First | 1 (reference) | 1 (reference) | 1 (reference) | |||
Second | 1.57 (0.92–2.68) | 0.094 | 1.11 (0.63–1.96) | 0.698 | 1.07 (0.60–1.91) | 0.813 |
Third | 2.11 (1.22–3.63) | 0.007 | 1.30 (0.72–2.32) | 0.374 | 1.18 (0.65–2.16) | 0.572 |
Fourth | 2.30 (1.20–4.40) | 0.012 | 0.91 (0.45–1.87) | 0.817 | 0.76 (0.36–1.59) | 0.475 |
Fifth | 4.13 (1.97–8.65) | <0.001 | 1.32 (0.58–3.00) | 0.507 | 1.10 (0.47–2.57) | 0.824 |
OR, odds ratio; CI, confidence interval.
aSerum cystatin C groups: first (<0.8 mg/L), second (0.8 mg/L), third (0.9 mg/L), fourth (1.0 mg/L), and fifth (>1.0 mg/L), bNon-adjusted model, cAge-adjusted (in total group, age- and sex-adjusted) model, dMultivariable model (additionally adjusting for body mass index, total cholesterol, and systolic blood pressure).